Skip to main content

Comments on Topical Formulations from a Medical Doctor

  • Chapter
  • First Online:
Skin Permeation and Disposition of Therapeutic and Cosmeceutical Compounds
  • 1265 Accesses

Abstract

In the treatment of skin disease, topical drugs and cosmetic products are required. In particular, moisturizers that consist of occlusive, humectant, and emollient properties are frequently used in dermatological practice. In this review, the importance of the use of moisturizers in atopic dermatitis, senile xerosis, and acne vulgaris is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hara J, Higuchi K, Okamoto R, Kawashima M, Imokawa G (2000) High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol 115(3):406–413

    Article  CAS  PubMed  Google Scholar 

  2. Seguchi T, Cui CY, Kusuda S, Takahashi M, Aisu K, Tezuka T (1996) Decreased expression of filaggrin in atopic skin. Arch Dermatol Res 288(8):442–446

    Article  CAS  PubMed  Google Scholar 

  3. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38(4):441–446

    Article  CAS  PubMed  Google Scholar 

  4. Osawa R, Akiyama M, Shimizu H (2011) Filaggrin gene defects and the risk of developing allergic disorders. Allergol Int 60(1):1–9

    Article  PubMed  Google Scholar 

  5. Bissonnette R, Maari C, Provost N, Bolduc C, Nigen S, Rougier A, Seite S (2010) A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis. J Cosmet Dermatol 9(1):16–21

    Article  PubMed  Google Scholar 

  6. Simpson E, Böhling A, Bielfeldt S, Bosc C, Kerrouche N (2013) Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor. J Dermatolog Treat 24(2):122–125

    Article  CAS  PubMed  Google Scholar 

  7. Seghers AC, Cai SC, Ho MSL, Giam YC, Tan L, Grönhagen CM, Tang MBY (2014) Evaluation of pseudoceramide moisturizer in patients with mild-to-moderate atopic dermatitis. Dermatol Ther 4(1):83–92

    Article  Google Scholar 

  8. Simpson EL, Chalmers JR, Hanifin JM et al (2014) Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol 134(4):818–823

    Article  PubMed  PubMed Central  Google Scholar 

  9. Horimukai K, Morita K, Narita M et al (2014) Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol 134(4):824–830

    Article  PubMed  Google Scholar 

  10. Takahashi M, Tezuka T (2004) The content of free amino acids in the stratum corneum is increased in senile xerosis. Arch Dermatol Res 295(10):448–452

    Article  CAS  PubMed  Google Scholar 

  11. Hoffman L, Subramanyan K, Johnson AW, Tharp MD (2008) Benefits of an emollient body wash for patients with chronic winter dry skin. Dermatol Ther 21(5):416–421

    Article  PubMed  Google Scholar 

  12. Baalham P, Birch I, Young M, Beale C (2011) Xerosis of the feet: a comparative study on the effectiveness of two moisturizers. Br J Community Nurs 16(12):591–592, 594–597

    Google Scholar 

  13. Christman JC, Fix DK, Lucus SC, Watson D, Desmier E, Wilkerson RJ, Fixler C (2012) Two randomized, controlled, comparative studies of the stratum corneum integrity benefits of tow cosmetic niacinamide/glycerin body moisturizers vs. conventional body moisturizers. J Drugs Dermatol 11(1):22–29

    CAS  PubMed  Google Scholar 

  14. Kawada A (2007) Acne phototherapy: a new evolution for the treatment of acne vulgaris. Expert Rev Dermatol 2(1):1–3

    Article  Google Scholar 

  15. Chularojanamontri L, Tuchinda P, Kulthanan K, Pongparit K (2014) Moisturizers for acne. What are their constituents? J Clin Aesthet Dermatol 7(5):36–44

    PubMed  PubMed Central  Google Scholar 

  16. Schorr ES, Sidou F, Kerrouche N (2012) Adjunctive use of a facial moisturizer SPF 30 containing ceramide precursor improves tolerability of topical tretinoin 0.05%: a randomized, investigator-blinded, split-face study. J Drugs Dermatol 11(9):1104–1107

    CAS  PubMed  Google Scholar 

  17. Del Rosso JQ, Brandt S (2013) The role of skin care as an integral component in the management of acne vulgaris. Part 2: tolerability and performance of a designated skin care regimen using a foam wash and moisturizer SPF 30 in patients with acne vulgaris undergoing active treatment. J Clin Aesthet Dermatol 6(12):28–36

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Akira Kawada M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Japan KK

About this chapter

Cite this chapter

Kawada, A. (2017). Comments on Topical Formulations from a Medical Doctor. In: Sugibayashi, K. (eds) Skin Permeation and Disposition of Therapeutic and Cosmeceutical Compounds. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56526-0_37

Download citation

Publish with us

Policies and ethics